First Tracks Biotherapeutics
Trade First Tracks Biotherapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About TRAX
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101.
TRAX Key Statistics
Stock Snapshot
As of today, First Tracks Biotherapeutics(TRAX) shares are valued at $45.33. The company's market cap stands at 1.55B.
During the trading session on 2026-08-10, First Tracks Biotherapeutics(TRAX) shares reached a daily high of $46.70 and a low of $43.50. At a current price of $45.33, the stock is +4.2% higher than the low and still -2.9% under the high.
Trading volume for First Tracks Biotherapeutics(TRAX) stock has reached 629.28K, versus its average volume of 873.84K.
The stock's 52-week range extends from a low of $14.72 to a high of $49.58.
The stock's 52-week range extends from a low of $14.72 to a high of $49.58.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.